• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国大学生罹患 B 群脑膜炎奈瑟菌疾病的风险增加。

US College Students Are at Increased Risk for Serogroup B Meningococcal Disease.

机构信息

Department of Pediatrics, University of Louisville, Louisville, Kentucky.

Department of Pediatrics, University of Colorado, Aurora, Colorado.

出版信息

J Pediatric Infect Dis Soc. 2020 Apr 30;9(2):244-247. doi: 10.1093/jpids/piz024.

DOI:10.1093/jpids/piz024
PMID:31077326
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7192401/
Abstract

Publicly available surveillance data, Centers for Disease Control and Prevention reports, and other sources suggest that college students in the United States are at increased risk for meningococcus serogroup B (MenB) disease. US surveillance data from 2015 to 2017 show that the incidence of invasive meningococcal disease (IMD) was greater among college students than among those not attending college; the average annual incidence of MenB disease was >5-fold higher among college students, and all college IMD outbreaks between 2011 and March 2019 were caused by MenB.

摘要

公开的监测数据、美国疾病控制与预防中心的报告和其他来源表明,美国大学生感染脑膜炎奈瑟菌 B 群(MenB)疾病的风险增加。2015 年至 2017 年美国的监测数据显示,与未上大学的人群相比,大学生罹患侵袭性脑膜炎球菌病(IMD)的发病率更高;大学生中 MenB 病的年平均发病率高出 5 倍以上,2011 年至 2019 年 3 月期间所有的大学生侵袭性脑膜炎球菌病疫情均由 MenB 引起。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f51/7192401/e6803eccc950/piz024f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f51/7192401/6b93f03a869c/piz024f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f51/7192401/e6803eccc950/piz024f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f51/7192401/6b93f03a869c/piz024f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f51/7192401/e6803eccc950/piz024f0002.jpg

相似文献

1
US College Students Are at Increased Risk for Serogroup B Meningococcal Disease.美国大学生罹患 B 群脑膜炎奈瑟菌疾病的风险增加。
J Pediatric Infect Dis Soc. 2020 Apr 30;9(2):244-247. doi: 10.1093/jpids/piz024.
2
Lessons from mass vaccination response to meningococcal B outbreaks at US universities.美国大学针对 B 型脑膜炎球菌爆发的大规模疫苗接种反应的经验教训。
Postgrad Med. 2020 Sep;132(7):614-623. doi: 10.1080/00325481.2020.1766265. Epub 2020 Jun 1.
3
Cost calculator for mass vaccination response to a US college campus outbreak of serogroup B meningococcal disease.针对美国大学校园 B 群脑膜炎球菌疾病爆发的大规模疫苗接种反应成本计算器。
Hum Vaccin Immunother. 2019;15(4):978-986. doi: 10.1080/21645515.2018.1556074. Epub 2019 Jan 16.
4
Meningococcal Carriage Evaluation in Response to a Serogroup B Meningococcal Disease Outbreak and Mass Vaccination Campaign at a College-Rhode Island, 2015-2016.2015 - 2016年罗德岛一所大学针对B群脑膜炎球菌病暴发及大规模疫苗接种运动开展的脑膜炎球菌携带情况评估
Clin Infect Dis. 2017 Apr 15;64(8):1115-1122. doi: 10.1093/cid/cix091.
5
University-Based Outbreaks of Meningococcal Disease Caused by Serogroup B, United States, 2013-2018.2013-2018 年美国基于大学的 B 群脑膜炎奈瑟菌引起的疾病爆发。
Emerg Infect Dis. 2019 Mar;25(3):434-440. doi: 10.3201/eid2503.181574.
6
First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University Outbreak.美国首次使用B群脑膜炎球菌疫苗应对大学疫情。
Pediatrics. 2015 May;135(5):798-804. doi: 10.1542/peds.2014-4015.
7
Serogroup B Meningococcal Disease Outbreak and Carriage Evaluation at a College - Rhode Island, 2015.2015年罗德岛一所大学的B群脑膜炎球菌病暴发及带菌情况评估
MMWR Morb Mortal Wkly Rep. 2015 Jun 12;64(22):606-7.
8
Randomized Trial of 2 Schedules of Meningococcal B Vaccine in Adolescents and Young Adults, Canada.青少年和青年人群脑膜炎 B 型疫苗 2 种免疫程序随机试验,加拿大。
Emerg Infect Dis. 2020 Mar;26(3):454-462. doi: 10.3201/eid2603.190160.
9
Serogroup B meningococcal vaccination practice patterns on college campuses.B 群脑膜炎球菌疫苗接种在大学校园的实践模式。
Vaccine. 2020 Oct 27;38(46):7350-7356. doi: 10.1016/j.vaccine.2020.09.035. Epub 2020 Oct 1.
10
Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults.美国针对循环和参考脑膜炎奈瑟菌 B 群菌株的血清杀菌活性:青少年和年轻成人中脑膜炎奈瑟菌 B 群(MenB)疫苗菌株覆盖范围的综述。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2212570. doi: 10.1080/21645515.2023.2212570.

引用本文的文献

1
A Narrative Review of College Meningococcal Vaccination Mandates Across the United States.美国高校脑膜炎球菌疫苗接种强制令的叙述性综述
Vaccines (Basel). 2025 Jul 24;13(8):784. doi: 10.3390/vaccines13080784.
2
Preventing Meningococcal Disease in US Adolescents and Young Adults Through Vaccination.通过接种疫苗预防美国青少年和青年的脑膜炎球菌病。
Infect Dis Ther. 2025 Jun 3. doi: 10.1007/s40121-025-01166-7.
3
Protocol for project MHISS: Mental Health and Immunodynamics of Social Stress.项目MHISS方案:社会压力下的心理健康与免疫动力学

本文引用的文献

1
University-Based Outbreaks of Meningococcal Disease Caused by Serogroup B, United States, 2013-2018.2013-2018 年美国基于大学的 B 群脑膜炎奈瑟菌引起的疾病爆发。
Emerg Infect Dis. 2019 Mar;25(3):434-440. doi: 10.3201/eid2503.181574.
2
Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents.MenB-FHbp 两剂和三剂方案诱导的杀菌应答的持久性和 4 年增强:青少年中一项 3 期扩展研究。
Vaccine. 2019 Mar 14;37(12):1710-1719. doi: 10.1016/j.vaccine.2018.11.073. Epub 2019 Feb 12.
3
Antibody persistence and booster response in adolescents and young adults 4 and 7.5 years after immunization with 4CMenB vaccine.
Brain Behav Immun Health. 2025 Mar 12;45:100977. doi: 10.1016/j.bbih.2025.100977. eCollection 2025 May.
4
Rationale for the Development of a Pentavalent Meningococcal Vaccine: A US-Focused Review.五价脑膜炎球菌疫苗研发的理论依据:以美国为重点的综述
Infect Dis Ther. 2022 Jun;11(3):937-951. doi: 10.1007/s40121-022-00609-9. Epub 2022 Mar 31.
5
Understanding the Factors Influencing Health Care Provider Recommendations about Adolescent Vaccines: A Proposed Framework.理解影响医疗保健提供者推荐青少年疫苗接种的因素:一个拟议的框架。
J Behav Med. 2023 Apr;46(1-2):356-365. doi: 10.1007/s10865-022-00296-4. Epub 2022 Feb 22.
6
Meningococcal Disease Outbreaks: A Moving Target and a Case for Routine Preventative Vaccination.脑膜炎球菌病暴发:一个不断变化的目标及常规预防性疫苗接种的理由
Infect Dis Ther. 2021 Dec;10(4):1949-1988. doi: 10.1007/s40121-021-00499-3. Epub 2021 Aug 11.
7
Factors Associated With Receipt of Meningococcal B Vaccine Among United States Adolescents, National Immunization Survey-Teen, 2017-2018.与美国青少年接种脑膜炎 B 疫苗相关的因素,全国免疫调查-青少年,2017-2018 年。
J Adolesc Health. 2021 Nov;69(5):769-773. doi: 10.1016/j.jadohealth.2021.04.029. Epub 2021 Jun 17.
8
Mass gatherings: a review of the scope for meningococcal vaccination in the Indian context.群体性集会:印度背景下脑膜炎球菌疫苗接种范围的评估。
Hum Vaccin Immunother. 2021 Jul 3;17(7):2216-2224. doi: 10.1080/21645515.2020.1871572. Epub 2021 Feb 19.
9
Epidemiological impact and cost-effectiveness of universal meningitis b vaccination among college students prior to college entry.大学生入学前普遍接种脑膜炎 B 疫苗的流行病学影响和成本效益。
PLoS One. 2020 Oct 9;15(10):e0239926. doi: 10.1371/journal.pone.0239926. eCollection 2020.
10
Parental awareness and utilization of meningococcal serogroup B vaccines in the United States.美国父母对脑膜炎 B 型球菌疫苗的认知和使用情况。
BMC Public Health. 2020 Jul 14;20(1):1109. doi: 10.1186/s12889-020-09181-8.
青少年和青年在接种 4CMenB 疫苗 4 年后和 7.5 年后的抗体持久性和加强应答。
Vaccine. 2019 Feb 21;37(9):1209-1218. doi: 10.1016/j.vaccine.2018.12.059. Epub 2019 Jan 26.
4
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2017.国家、地区、州和选定的局部地区 13-17 岁青少年疫苗接种覆盖率 - 美国,2017 年。
MMWR Morb Mortal Wkly Rep. 2018 Aug 24;67(33):909-917. doi: 10.15585/mmwr.mm6733a1.
5
Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine.预测脑膜炎奈瑟菌 B 群分离株对新型预防疫苗 bivalent rLP2086 诱导的杀菌抗体的敏感性。
mBio. 2018 Mar 13;9(2):e00036-18. doi: 10.1128/mBio.00036-18.
6
Meningococcal carriage among a university student population - United States, 2015.2015 年美国大学生群体中的脑膜炎奈瑟菌带菌情况。
Vaccine. 2018 Jan 2;36(1):29-35. doi: 10.1016/j.vaccine.2017.11.040. Epub 2017 Nov 26.
7
Meningococcal Antigen Typing System (MATS)-Based Serogroup B Coverage Prediction for the MenB-4C Vaccine in the United States.基于脑膜炎球菌抗原分型系统(MATS)对美国B群脑膜炎球菌4C型疫苗(MenB-4C)血清群覆盖率的预测
mSphere. 2017 Nov 15;2(6). doi: 10.1128/mSphere.00261-17. eCollection 2017 Nov-Dec.
8
Current Epidemiology and Trends in Meningococcal Disease-United States, 1996-2015.当前脑膜炎奈瑟菌病的流行病学和趋势-美国,1996-2015 年。
Clin Infect Dis. 2018 Apr 3;66(8):1276-1281. doi: 10.1093/cid/cix993.
9
Notes from the Field: Outbreak of Serogroup B Meningococcal Disease at a University - California, 2016.现场记录:2016 年加利福尼亚某大学 B 群脑膜炎球菌病爆发
MMWR Morb Mortal Wkly Rep. 2016 May 27;65(20):520-1. doi: 10.15585/mmwr.mm6520a3.
10
Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015.《2015 年免疫实践咨询委员会关于青少年和青年使用 B 群脑膜炎球菌疫苗的建议》。
MMWR Morb Mortal Wkly Rep. 2015 Oct 23;64(41):1171-6. doi: 10.15585/mmwr.mm6441a3.